Search Orphan Drug Designations and Approvals
-
Generic Name: | selumetinib |
---|---|
Date Designated: | 04/15/2015 |
Orphan Designation: | Treatment of uveal melanoma. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 12/15/2015 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AstraZeneca Pharmaceuticals LP 1800 Concord Pike P. O. Box 8355 Wilmington, Delaware 19803 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-